Cargando…
A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms
Pancreatic neuroendocrine neoplasms (pNENs) are a group of clinically rare and heterogeneous diseases of the pancreas. However, the prognostic factors for this disease in patients still remain controversial. The purpose of our study is to evaluate the predictive roles of those prognostic factors for...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940798/ https://www.ncbi.nlm.nih.gov/pubmed/29739948 http://dx.doi.org/10.1038/s41598-018-24072-0 |
_version_ | 1783321158385401856 |
---|---|
author | Gao, Yong Gao, Hao Wang, Guangfu Yin, Lingdi Xu, Wenbin Peng, Yunpeng Wu, Junli Jiang, Kuirong Miao, Yi |
author_facet | Gao, Yong Gao, Hao Wang, Guangfu Yin, Lingdi Xu, Wenbin Peng, Yunpeng Wu, Junli Jiang, Kuirong Miao, Yi |
author_sort | Gao, Yong |
collection | PubMed |
description | Pancreatic neuroendocrine neoplasms (pNENs) are a group of clinically rare and heterogeneous diseases of the pancreas. However, the prognostic factors for this disease in patients still remain controversial. The purpose of our study is to evaluate the predictive roles of those prognostic factors for pNENs. All related articles published until Sep 17, 2017 were identified via PubMed, EMBASE, Web of Science, Ovid and the Cochrane Library. Studies that examined the prognostic factors of pNENs were enrolled. 17 articles (2822 patients) were finally included in this study. The pooled data suggested that patients with positive surgical resection margin and lymph node, advanced G stage and TMN stage, organ metastasis, vascular invasion and the necrosis of specimens had a decreased overall survival for pNENs. Similarly, patients with functional tumors might have a poor prognosis. However, age, gender, surgical type and size of tumor could not be regarded as prognostic factors for pNENs. Our analytic data demonstrated that surgical resection margin, G stage, TMN stage, lymph node, metastasis, vascular invasion and the necrosis could be prognostic factors for pNENs. Our study may assist doctors to screen patients with different prognosis more efficiently during follow-up and select appropriate treatment measures. |
format | Online Article Text |
id | pubmed-5940798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-59407982018-05-11 A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms Gao, Yong Gao, Hao Wang, Guangfu Yin, Lingdi Xu, Wenbin Peng, Yunpeng Wu, Junli Jiang, Kuirong Miao, Yi Sci Rep Article Pancreatic neuroendocrine neoplasms (pNENs) are a group of clinically rare and heterogeneous diseases of the pancreas. However, the prognostic factors for this disease in patients still remain controversial. The purpose of our study is to evaluate the predictive roles of those prognostic factors for pNENs. All related articles published until Sep 17, 2017 were identified via PubMed, EMBASE, Web of Science, Ovid and the Cochrane Library. Studies that examined the prognostic factors of pNENs were enrolled. 17 articles (2822 patients) were finally included in this study. The pooled data suggested that patients with positive surgical resection margin and lymph node, advanced G stage and TMN stage, organ metastasis, vascular invasion and the necrosis of specimens had a decreased overall survival for pNENs. Similarly, patients with functional tumors might have a poor prognosis. However, age, gender, surgical type and size of tumor could not be regarded as prognostic factors for pNENs. Our analytic data demonstrated that surgical resection margin, G stage, TMN stage, lymph node, metastasis, vascular invasion and the necrosis could be prognostic factors for pNENs. Our study may assist doctors to screen patients with different prognosis more efficiently during follow-up and select appropriate treatment measures. Nature Publishing Group UK 2018-05-08 /pmc/articles/PMC5940798/ /pubmed/29739948 http://dx.doi.org/10.1038/s41598-018-24072-0 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Gao, Yong Gao, Hao Wang, Guangfu Yin, Lingdi Xu, Wenbin Peng, Yunpeng Wu, Junli Jiang, Kuirong Miao, Yi A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms |
title | A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms |
title_full | A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms |
title_fullStr | A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms |
title_full_unstemmed | A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms |
title_short | A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms |
title_sort | meta-analysis of prognostic factor of pancreatic neuroendocrine neoplasms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940798/ https://www.ncbi.nlm.nih.gov/pubmed/29739948 http://dx.doi.org/10.1038/s41598-018-24072-0 |
work_keys_str_mv | AT gaoyong ametaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT gaohao ametaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT wangguangfu ametaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT yinlingdi ametaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT xuwenbin ametaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT pengyunpeng ametaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT wujunli ametaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT jiangkuirong ametaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT miaoyi ametaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT gaoyong metaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT gaohao metaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT wangguangfu metaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT yinlingdi metaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT xuwenbin metaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT pengyunpeng metaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT wujunli metaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT jiangkuirong metaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms AT miaoyi metaanalysisofprognosticfactorofpancreaticneuroendocrineneoplasms |